Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$2.69
+7.6%
$1.69
$1.32
$4.98
$629.35M2.597.00 million shs12.01 million shs
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$6.35
+42.6%
$5.29
$0.23
$14.11
$199.35M1.82918,255 shs3.10 million shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$29.60
+12.2%
$13.63
$9.76
$29.87
$750.20M1.191.58 million shs1.33 million shs
SiBone stock logo
SIBN
SiBone
$15.21
-0.8%
$15.60
$11.70
$20.05
$661.35M0.83455,846 shs768,463 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-2.34%+29.46%+61.09%+29.46%+34.32%
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
0.00%0.00%+43.88%+0.55%+2,039.97%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-0.75%+21.11%+138.82%+115.60%+144.35%
SiBone stock logo
SIBN
SiBone
+5.80%+4.14%-5.89%-16.87%+15.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$2.69
+7.6%
$1.69
$1.32
$4.98
$629.35M2.597.00 million shs12.01 million shs
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$6.35
+42.6%
$5.29
$0.23
$14.11
$199.35M1.82918,255 shs3.10 million shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$29.60
+12.2%
$13.63
$9.76
$29.87
$750.20M1.191.58 million shs1.33 million shs
SiBone stock logo
SIBN
SiBone
$15.21
-0.8%
$15.60
$11.70
$20.05
$661.35M0.83455,846 shs768,463 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-2.34%+29.46%+61.09%+29.46%+34.32%
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
0.00%0.00%+43.88%+0.55%+2,039.97%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-0.75%+21.11%+138.82%+115.60%+144.35%
SiBone stock logo
SIBN
SiBone
+5.80%+4.14%-5.89%-16.87%+15.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.40
Hold$3.0011.52% Upside
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
3.00
Buy$10.0057.60% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.50
Moderate Buy$19.67-33.56% Downside
SiBone stock logo
SIBN
SiBone
2.50
Moderate Buy$23.6755.60% Upside

Current Analyst Ratings Breakdown

Latest BSGM, CLPT, SIBN, and BFLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
SiBone stock logo
SIBN
SiBone
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
SiBone stock logo
SIBN
SiBone
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/11/2025
SiBone stock logo
SIBN
SiBone
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$25.00
8/5/2025
SiBone stock logo
SIBN
SiBone
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$25.00
8/4/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingPositive$2.00
8/1/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperformMarket Perform
8/1/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$8.00 ➝ $9.00
(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$82.06M8.25N/AN/A$0.79 per share3.41
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$13K15,334.89N/AN/A($0.09) per share-70.50
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$31.39M26.81N/AN/A$0.92 per share32.17
SiBone stock logo
SIBN
SiBone
$167.18M3.92N/AN/A$3.98 per share3.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$10.33MN/A0.00N/AN/AN/A-5,336.99%-90.03%11/13/2025 (Estimated)
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$18.91M-$0.81N/AN/AN/A-66.15%-94.44%-51.58%11/6/2025 (Estimated)
SiBone stock logo
SIBN
SiBone
-$30.91M-$0.56N/AN/AN/A-12.83%-14.20%-10.38%11/11/2025 (Estimated)

Latest BSGM, CLPT, SIBN, and BFLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2025Q2 2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$0.04-$0.74-$0.70-$0.74N/AN/A
8/12/2025Q2 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.20-$0.21-$0.01-$0.21$9.20 million$9.22 million
8/4/2025Q2 2025
SiBone stock logo
SIBN
SiBone
-$0.19-$0.14+$0.05-$0.14$48.12 million$48.63 million
8/1/2025Q2 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
5.68
4.14
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/A
0.03
0.03
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.46
7.30
6.45
SiBone stock logo
SIBN
SiBone
0.21
8.38
7.00

Institutional Ownership

CompanyInstitutional Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
7.16%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
SiBone stock logo
SIBN
SiBone
98.11%

Insider Ownership

CompanyInsider Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
25.18%
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
24.80%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.97%
SiBone stock logo
SIBN
SiBone
4.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460251.74 million188.35 millionOptionable
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
5031.42 million23.63 millionNo Data
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11028.43 million26.45 millionOptionable
SiBone stock logo
SIBN
SiBone
35043.14 million41.42 millionOptionable

Recent News About These Companies

SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 Shares
SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 Shares
SiBone (NASDAQ:SIBN) versus RxSight (NASDAQ:RXST) Critical Review
Harbor Capital Advisors Inc. Raises Stake in SiBone $SIBN
SiBone $SIBN Shares Bought by Goldman Sachs Group Inc.
SiBone (NASDAQ:SIBN) SVP Sells $52,065.56 in Stock
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$2.69 +0.19 (+7.60%)
Closing price 03:59 PM Eastern
Extended Trading
$2.71 +0.02 (+0.89%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Biosig Technologies stock logo

Biosig Technologies NASDAQ:BSGM

$6.34 +1.90 (+42.58%)
Closing price 09/11/2025
Extended Trading
$6.34 0.00 (0.00%)
As of 09/11/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$29.60 +3.21 (+12.16%)
Closing price 04:00 PM Eastern
Extended Trading
$29.99 +0.39 (+1.32%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

SiBone stock logo

SiBone NASDAQ:SIBN

$15.21 -0.12 (-0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$15.20 -0.01 (-0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.